Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01479
Species: Homo sapiens
Position : chr17:39725049-39725326
Year: 2018
Title: A novel HER2 gene body enhancer contributes to HER2 expression.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: breast carcinoma
PMID:  29035388
MONDO: MONDO:0004989
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: HEK293T reporter cells
CVCL ID: CVCL_0063
Cell Type: breast carcinoma cell lines; HEK293T reporter cell
Experiment Type: functional gene-body enhancer-core mapping plus TF and epigenetic validation
High Throughput Method: ENCODE DNase/H3K4me1/H3K27ac integration; TFAP2C ChIP-seq; primary-tumor methylation-expression analysis
Low Throughput Method: serial reporter deletion mapping; luciferase; EMSA/supershift; TFAP2C ChIP-qPCR; TFAP2C siRNA; CRISPR-Cas9 intron-21 editing; dCas9-DNMT3A targeted methylation; bisulfite sequencing; RT-PCR; western blot
About Target Gene
Target gene : ERBB2
About TF
TF name : TFAP2C
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
TFAP2C Validated transcriptional targets of TAp63 isoforms pid 54
Enhancer Associated Network
Overlapping Enhancers (hg38) 4 found
Enhancer ID Position Tissue Cell Disease
E_01458 chr17:39725049-39725326 breast breast carcinoma cell lines; HEK293T reporter cell breast carcinoma
E_01473 chr17:39725049-39725326 breast malignant cell breast carcinoma
E_01474 chr17:39725049-39725326 breast malignant cell breast carcinoma
E_01475 chr17:39725049-39725326 breast malignant cell breast carcinoma
Expression of Target Genes for the Enhancer